[Pleomorphic T-cell lymphoma. Its diagnosis and the therapeutic possibilities]

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia.

Blood cancer journal·2016

Detection of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia by Analysis of Gene Rearrangements and Correlation with Early Relapses.

Leukemia & lymphoma·2016

Change in prognostic factors.

Leukemia supplements·2016

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation.

Leukemia·2014

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia.

Leukemia·2012

Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.

Blood cancer journal·2012

[Multiple myeloma as an occupational disease after long-term benzene exposure in a distillery - a case report].

Deutsche medizinische Wochenschrift (1946)·2026

[Chronic Cough].

Deutsche medizinische Wochenschrift (1946)·2026

[Lipid-lowering therapy in transition: implications of the ESC/EAS focused update].

Deutsche medizinische Wochenschrift (1946)·2026

[Re-thinking Organ Donation: Structural development, Multiprofessional Collaboration, and Data-Driven Research].

Deutsche medizinische Wochenschrift (1946)·2026

[Lung Ultrasonography in Intensive Care Medicine].

Deutsche medizinische Wochenschrift (1946)·2026

[Cholangiocarcinoma as a model disease: new pathways in personalized medicine].

Deutsche medizinische Wochenschrift (1946)·2026

The Evolution of Immunotherapy Revolution in Lung Cancer: A 20-Year Perspective.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

Lessons learned from clinical trials of thymic stromal lymphopoietin (TSLP) inhibition.

The Journal of allergy and clinical immunology·2026

Thymic stromal lymphopoietin as a therapeutic target for the treatment of eosinophilic esophagitis.

Clinical and translational gastroenterology·2026

Primary hepatic interdigitating dendritic cell sarcoma: A rarity unveiled.

Indian journal of pathology & microbiology·2026

Treatment Patterns, Outcomes and Survival Trends in T-Cell Prolymphocytic Leukemia: A Nationwide Population-Based Study in the Netherlands.

European journal of haematology·2026

Peritoneal Desmoplastic Small Round Cell Tumor on FDG PET/CT.

Clinical nuclear medicine·2026

Related Experiment Videos

[Pleomorphic T-cell lymphoma. Its diagnosis and the therapeutic possibilities]

Related Concept Videos

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia.

Detection of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia by Analysis of Gene Rearrangements and Correlation with Early Relapses.

Change in prognostic factors.

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation.

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia.

Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.

[Multiple myeloma as an occupational disease after long-term benzene exposure in a distillery - a case report].

[Chronic Cough].

[Lipid-lowering therapy in transition: implications of the ESC/EAS focused update].

[Re-thinking Organ Donation: Structural development, Multiprofessional Collaboration, and Data-Driven Research].

[Lung Ultrasonography in Intensive Care Medicine].

[Cholangiocarcinoma as a model disease: new pathways in personalized medicine].

The Evolution of Immunotherapy Revolution in Lung Cancer: A 20-Year Perspective.

Lessons learned from clinical trials of thymic stromal lymphopoietin (TSLP) inhibition.

Thymic stromal lymphopoietin as a therapeutic target for the treatment of eosinophilic esophagitis.

Primary hepatic interdigitating dendritic cell sarcoma: A rarity unveiled.

Treatment Patterns, Outcomes and Survival Trends in T-Cell Prolymphocytic Leukemia: A Nationwide Population-Based Study in the Netherlands.

Peritoneal Desmoplastic Small Round Cell Tumor on FDG PET/CT.

Related Experiment Videos

[Pleomorphic T-cell lymphoma. Its diagnosis and the therapeutic possibilities]

Related Concept Videos

Related Articles